Cargando…
Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study
BACKGROUND: Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is one of the main antimicrobial-resistant pathogens. Little data are available on how biofilm formation (BF) contributes to EC-caused bloodstream infection (BSI) in cancer patients. This study investigated the impact of...
Autores principales: | Zhang, Qing, Gao, Hao-Yang, Li, Ding, Li, Zheng, Qi, Shan-Shan, Zheng, Shan, Bai, Chang-Sen, Zhang, Si-He |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377049/ https://www.ncbi.nlm.nih.gov/pubmed/30809097 http://dx.doi.org/10.2147/IDR.S192072 |
Ejemplares similares
-
A TTP-incorporated scoring model for predicting mortality of solid tumor patients with bloodstream infection caused by Escherichia coli
por: Zhang, Qing, et al.
Publicado: (2021) -
1054. Biofilm Formation Among Escherichia coli Bloodstream Infection Isolates Is Associated With Source of Bacteremia and Bacterial Sequence Type
por: Chang, Carolyn, et al.
Publicado: (2018) -
Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019
por: Bai, Changsen, et al.
Publicado: (2022) -
Bacteria-Derived Carbon Dots Inhibit Biofilm Formation of Escherichia coli without Affecting Cell Growth
por: Lin, Fengming, et al.
Publicado: (2018) -
Rcs phosphorelay affects the sensitivity of Escherichia coli to plantaricin BM-1 by regulating biofilm formation
por: Bian, Zheng, et al.
Publicado: (2022)